Skip to content

Procedures and Follow-up of Percutaneous Tracheostomy in Intensive Care Unit

Procedures, Complications and Follow-up of Percutaneous Tracheostomies in Intensive Care Unit

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01792258
Enrollment
200
Registered
2013-02-15
Start date
2012-06-30
Completion date
2017-01-31
Last updated
2016-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Failure, Heart Failure, Neurological Disease

Keywords

Percutaneous tracheostomy, Intensive Care Unit, Ineffective Airway Clearance, Weaning failure

Brief summary

Tracheostomy is worldwide performed in Intensive Care Unit (ICU). According to the current literature, indication for percutaneous tracheostomy (PDT) in ICU are: difficult prolonged weaning, prolonged mechanical ventilation, loss of airway reflex, copious secretions, upper airway obstruction. Many studies have focused on the comparison between different PDT techniques and complication. The aim of our study is to evaluate the procedural features, complications, ICU mortality, quality of life, post-discharge mortality of patients undergoing different PDT techniques performed in ICU.

Interventions

Percutaneous tracheostomies will be performed with the kit commercially available in the current clinical practice.

Sponsors

University of Genova
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 82 Years
Healthy volunteers
No

Inclusion criteria

* age \>18 * indication for tracheostomy

Exclusion criteria

* infectious disease of neck

Design outcomes

Primary

MeasureTime frame
Safety of percutaneous tracheostomyat the beginning and at the end of the procedure

Secondary

MeasureTime frameDescription
Late complicationsfrom the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks)Late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma.
Quality of lifeat 3, 6 and 12 months after tracheostomyThe investigator will use the EURO-QOL
Early complicationsin the first 24 hours from the end of the procedureEarly complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax
Quality of voiceAt 3,6, 12 months after tracheostomythe investigator will use a KAY elemetrics analyzer.
Mortalityat 3, 6 and 12 months from tracheostomy
Evaluation of organ functionAt 3, 6 , and 12 months after tracheostomyThe investigator will perform a flexible fiberoptic laryngoscopy.

Countries

Italy

Contacts

Primary ContactPaolo Pelosi, professor
ppelosi@hotmail.com+39 010 5553136

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026